Bolt Biotherapeutics Inc. (BOLT)
Bolt Biotherapeutics Statistics
Share Statistics
Bolt Biotherapeutics has 38.34M shares outstanding. The number of shares has increased by 0.56% in one year.
| 38.34M |
| 0.56% |
| 0.17% |
| 48.81% |
| n/a |
| 638 |
| 0.19% |
Short Selling Information
The latest short interest is 256.53K, so 0.67% of the outstanding shares have been sold short.
| 256.53K |
| 0.67% |
| 0.67% |
| 2.07 |
Valuation Ratios
The PE ratio is -0.32 and the forward PE ratio is -0.33. Bolt Biotherapeutics's PEG ratio is 0.03.
| -0.32 |
| -0.33 |
| 2.66 |
| 0.7 |
| 0.36 |
| -0.33 |
| 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bolt Biotherapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.2, with a Debt / Equity ratio of 0.44.
| 3.2 |
| 3.2 |
| 0.44 |
| -0.38 |
| -0.41 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $147,884.62 |
| $-1,213,807.69 |
| 52 |
| 0.08 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -61.33% in the last 52 weeks. The beta is 0.91, so Bolt Biotherapeutics's price volatility has been higher than the market average.
| 0.91 |
| -61.33% |
| 0.35 |
| 0.51 |
| 40.53 |
| 331,980 |
Income Statement
In the last 12 months, Bolt Biotherapeutics had revenue of 7.69M and earned -63.12M in profits. Earnings per share was -1.65.
| 7.69M |
| 5.51M |
| -73.05M |
| -63.12M |
| -66.45M |
| -68.24M |
| -1.65 |
Balance Sheet
The company has 7.21M in cash and 25.21M in debt, giving a net cash position of -18M.
| 7.21M |
| 25.21M |
| -18M |
| -427.4M |
| 85.86M |
| 28.95M |
Cash Flow
In the last 12 months, operating cash flow was -61.29M and capital expenditures -41K, giving a free cash flow of -61.33M.
| -61.29M |
| -41K |
| -61.33M |
| -1.61 |
Margins
Gross margin is 71.64%, with operating and profit margins of -949.91% and -820.78%.
| 71.64% |
| -949.91% |
| -820.78% |
| -820.78% |
| -864.17% |
| -949.91% |
| -797.53% |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for BOLT is $2.5, which is 762.1% higher than the current price. The consensus rating is "Hold".
| $2.5 |
| 762.1% |
| Hold |
| 3 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -8.97 |
| 2 |